{"id":71454,"date":"2025-09-18T10:24:14","date_gmt":"2025-09-18T10:24:14","guid":{"rendered":"https:\/\/kanboapp.com\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/"},"modified":"2025-09-18T10:24:14","modified_gmt":"2025-09-18T10:24:14","slug":"navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers","status":"publish","type":"page","link":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/","title":{"rendered":"Navigating the Critical Challenges and Emerging Opportunities in Risk Visibility for Pharmaceutical CHC Data Domain Managers"},"content":{"rendered":"<style> @media(min-width:1728px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{    flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;}  .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy { margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media(min-width: 1440px) and (max-width:1727px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 1024px) and (max-width:1439px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2{ display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 782px) and (max-width:1023px) { .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;}  .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:60%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:32px!important; } .pasek-prawy {margin-right:32px!important; } } @media (max-width:781px) {  .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 16px!important; margin-right: 16px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:100%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:none!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:16px!important; } .pasek-prawy {margin-right:16px!important; } } .prawy-link a:hover { color:#145A92!important} .banner { margin-top:80px; margin-bottom:80px; } .jazda-nowsza { position:sticky!important; top: 120px; overflow: auto; max-height: 85vh; }  .fobrazek { margin-bottom: -40px!important; } .sekcja5-przycisk a:hover { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; }  .sekcja5-przycisk a:focus { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; } .vlp-layout-blogs .vlp-block-0 {font-weight: 600!important; } .prawy-tytul-pulpit {font-size:19px!important;} .ct-container-narrow {max-width: 1200px!important;}  :nth-last-child(1 of .tekst-para) {margin-bottom: 0px!important;} <\/style><script> function lewemenu(zm) { var elements = document.getElementsByClassName(\"menu-lewe\"); var i,link1,link2; for (i = 0; i < elements.length; i++) {    link1 = elements[i].getElementsByTagName(\"a\");     link1[0].style.fontWeight = \"600\";     link1[0].style.backgroundColor= \"#FAFAFA\"; } link2 = elements[zm].getElementsByTagName(\"a\"); link2[0].style.fontWeight = \"600\"; link2[0].style.backgroundColor= \"#E9F4FE\"; } <\/script><div class=\"wp-block-getwid-section alignfull alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background has-background\" style=\"background-color:#fafafa\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><div class=\"wp-block-columns alignfull artykul is-layout-flex wp-container-core-columns-is-layout-f96e3eba wp-block-columns-is-layout-flex\" style=\"margin-top:0px;margin-bottom:0px\"><div class=\"wp-block-column pasek-lewy spis jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><p class=\"menu-lewe wp-elements-8aa731ec406ecba2ad6fa605260385fa wp-block-paragraph\" onclick=\"lewemenu(0)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section1\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section1\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Why change?<\/a><\/p><p class=\"menu-lewe wp-elements-686b2acc4795818a0c680e7530ad9a1c wp-block-paragraph\" onclick=\"lewemenu(1)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section2\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section2\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Background \/ Definition<\/a><\/p><p class=\"menu-lewe wp-elements-da5b36e0f467091554977b2297d68899 wp-block-paragraph\" onclick=\"lewemenu(2)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section3\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section3\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Case-Style Mini-Examples<\/a><\/p><p class=\"menu-lewe wp-elements-d04edcb63f452a8e5e50b0f2b287af3e wp-block-paragraph\" onclick=\"lewemenu(3)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section4\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section4\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will change?<\/a><\/p><p class=\"menu-lewe wp-elements-20cb8d43b65976ea9b30139ce3895d78 wp-block-paragraph\" onclick=\"lewemenu(4)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section5\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section5\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will not change?<\/a><\/p><p class=\"menu-lewe wp-elements-d52cb855d6092ce31a65340e08289f25 wp-block-paragraph\" onclick=\"lewemenu(5)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section6\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section6\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Key management questions (Q\/A)<\/a><\/p><p class=\"menu-lewe wp-elements-819aa31ebc4432ea77ba2ccbd2b0fa9d wp-block-paragraph\" onclick=\"lewemenu(6)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section7\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section7\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Atomic Facts<\/a><\/p><p class=\"menu-lewe wp-elements-08a6d410c321dc2f1796cd832a74c17b wp-block-paragraph\" onclick=\"lewemenu(7)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section8\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section8\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Mini-FAQ<\/a><\/p><p class=\"menu-lewe wp-elements-413379145266ece2aabc5fa2319b125e wp-block-paragraph\" onclick=\"lewemenu(8)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section9\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section9\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Data Table<\/a><\/p><p class=\"menu-lewe wp-elements-f5e37dc9fae0e991ba0794a5e55dbd0a wp-block-paragraph\" onclick=\"lewemenu(9)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section10\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section10\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Answer Capsule<\/a><\/p><p class=\"menu-lewe wp-elements-3ef50ccc4037363573e8fc9e59d26940 wp-block-paragraph\" onclick=\"lewemenu(10)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section11\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#section11\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/a><\/p><\/div><\/div><\/div><div class=\"wp-block-column kolumna-tekst is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-getwid-section alignfull sekcja-tekst alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><h1 class=\"wp-block-heading tytulek\" style=\"margin-bottom:40px;font-style:normal;font-weight:700;letter-spacing:-0.34px;line-height:1.2\">Navigating the Critical Challenges and Emerging Opportunities in Risk Visibility for Pharmaceutical CHC Data Domain Managers<\/h1><h2 class=\"wp-block-heading naglowek-duzy\" id=\"section1\">Why change?<\/h2><p class=\"tekst-para wp-block-paragraph\">Risk visibility in the pharmaceutical industry involves identifying, assessing, and managing various risks across different stages of drug development, manufacturing, and distribution. Pressure around risk visibility is significant for several reasons:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Regulatory Compliance: Pharmaceutical companies face stringent regulations from agencies such as the FDA, EMA, and others. Failure to maintain visibility into risks can lead to non-compliance, resulting in fines, recalls, or even facilities being shut down.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Public Health: Pharmaceuticals directly impact patient health. Undetected risks can lead to adverse drug reactions, which can cause harm to patients and lead to huge legal liabilities.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Financial Performance: Inadequate risk visibility can result in financial losses due to failed projects, unexpected delays, or increased operational costs. <\/p><p class=\"tekst-para wp-block-paragraph\">4. Reputation Management: A single incident of oversight due to lack of risk visibility can tarnish a pharmaceutical company's reputation. In an industry reliant on trust, this can lead to long-term damage to brand perception.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Innovation and Development Pressure: The rapid pace of innovation necessitates a constant balancing act between speed to market and thorough risk assessment. This creates pressure to simultaneously innovate and keep risks in check.<\/p><p class=\"tekst-para wp-block-paragraph\">Quantifying the risk of inaction:<\/p><p class=\"tekst-para wp-block-paragraph\">- Project Costs: For large pharmaceutical developments, a lack of risk visibility can increase project costs by 20-50% due to unexpected issues, delays, and rework.<\/p><p class=\"tekst-para wp-block-paragraph\">- Time to Market: Delays in identifying and mitigating risks can extend the time to market by 6-12 months, resulting in lost revenues ranging from millions to billions, depending on the drug.<\/p><p class=\"tekst-para wp-block-paragraph\">- Quality and Recall Costs: Drug recalls can cost companies an average of $8 million per recall in direct costs alone, not counting the long-term impact on sales and reputation.<\/p><p class=\"tekst-para wp-block-paragraph\">- Legal and Fines: Potential legal liabilities stemming from failures in risk management can range from millions to billions in settlement fines and class action lawsuits.<\/p><p class=\"tekst-para wp-block-paragraph\">To mitigate these challenges, pharmaceutical companies often adopt comprehensive risk management frameworks. While specific software solutions can aid in enhancing risk visibility, it is important to maintain flexibility and adaptability to various tools. For instance, KanBo provides an example where teams can use visual boards, decks, and cards to plan, track, and manage risks, facilitating transparency and collaboration across departments. However, the key is to establish a culture of continuous risk awareness and proactive management that can adapt and integrate with any suitable technology.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section2\">Background \/ Definition<\/h3><p class=\"tekst-para wp-block-paragraph\">In the context of a CHC Data Domain Manager - Customer in the pharmaceutical industry, risk visibility is critical for effectively managing data projects, ensuring quality control, and meeting regulatory compliance. Risk visibility involves recognizing, understanding, and mitigating risks that could potentially hinder the progress, compliance, or success of projects and tasks. Key terms related to risk visibility include:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Card Blocker: An impediment in KanBo that halts task progression. There are various kinds:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Local Blockers: Specific to a team or project.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Global Blockers: Widespread, affecting multiple projects or teams.<\/p><p class=\"tekst-para wp-block-paragraph\">   - On-demand Blockers: Emergent issues needing immediate attention.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Date Conflict: Occurs when there's an overlap or inconsistency in the schedule of tasks. This is critical in pharmaceuticals where timing in production and research phases is essential.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Card Relation: Defines dependencies between tasks, helping delineate task orders and dependencies. Essential for managing the complexity of pharmaceutical projects which often involve interrelated tasks.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Notification: Alerts provided to team members about critical changes or updates in tasks and projects. This ensures that everyone is informed and can react promptly to new developments.<\/p><p class=\"tekst-para wp-block-paragraph\">How KanBo Reframes Risk Visibility:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Visible Blockers: In KanBo, card blockers make issues transparent. By categorizing them into local, global, and on-demand blockers, managers can prioritize their resolution effectively. This is crucial in pharmaceutical settings where delays can have significant impacts.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Mapped Dependencies: With card relations, KanBo allows managers to visualize task dependencies and sequences. This feature aids in identifying potential risks in task overlaps or dependencies, preventing bottlenecks and ensuring efficient workflow in pharmaceutical project phases.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Notifications: KanBo\u2019s notification system provides real-time updates on blockers, date conflicts, and important changes in card statuses or task relations. This ensures that team members are always informed and can make timely decisions to mitigate risks, maintaining project momentum and compliance.<\/p><p class=\"tekst-para wp-block-paragraph\">By leveraging these features, a CHC Data Domain Manager in pharmaceuticals can enhance risk visibility through clear communication, proactive risk management, and adaptable project handling, all while maintaining a seamless and informed workflow.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section3\">Case-Style Mini-Examples<\/h3><p class=\"tekst-para wp-block-paragraph\"> Case Example: Risk Visibility Challenges and Solutions for a CHC Data Domain Manager in Pharmaceuticals<\/p><p class=\"tekst-para wp-block-paragraph\"> Traditional Scenario: Challenges with Risk Visibility<\/p><p class=\"tekst-para wp-block-paragraph\">Context:<\/p><p class=\"tekst-para wp-block-paragraph\">As a CHC Data Domain Manager responsible for overseeing data-driven projects involving drug development, you are expected to ensure precise and timely risk visibility. Traditionally, you rely on spreadsheets and email threads to track tasks, deadlines, and issues across various teams, creating several challenges:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Delayed Communication:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Identifying and addressing risks like drug interaction problems were time-consuming due to infrequent updates and scattered information exchanges.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Emails went unchecked, leading to missed alerts about critical compliance deadlines.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Inefficient Task Tracking:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Multiple tasks lacked a coherent display of dependencies, causing confusion about task order in complex projects such as clinical trial data analysis.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Overlapping schedules weren\u2019t addressed until too late, resulting in bottlenecks.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Risk Recognition Delays:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Potential risks lingered without prompt identification, leading to increased financial costs and compliance issues.<\/p><p class=\"tekst-para wp-block-paragraph\">   - No centralized, real-time system meant delayed visibility of emerging global risks.<\/p><p class=\"tekst-para wp-block-paragraph\"> KanBo Implementation: Streamlining Task and Risk Management<\/p><p class=\"tekst-para wp-block-paragraph\">Transformation with KanBo:<\/p><p class=\"tekst-para wp-block-paragraph\">Utilizing KanBo, the CHC Data Domain Manager reshapes the way risk visibility is managed, ensuring efficiency and proactive response.<\/p><p class=\"tekst-para wp-block-paragraph\">1. Card Blocker Implementation:<\/p><p class=\"tekst-para wp-block-paragraph\">   - The manager applies card blockers for critical or overdue tasks, categorically flagging local or global issues. This facilitates immediate attention and resolution, preventing bottlenecks in projects such as drug sample analysis.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Transparency in impediments prompts timely strategy adjustments and rapid resolution, crucial for maintaining compliance and safeguarding public health.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Date Conflict Resolution:<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo\u2019s date management feature enables instant detection of date conflicts between sorting of card relations, where overlapping or incorrect task scheduling previously led to execution delays.<\/p><p class=\"tekst-para wp-block-paragraph\">   - This alignment reduces project overrun and improves the drug's time to market, enhancing financial outcomes.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Enhanced Card Relation Mapping:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Tasks are now broken down with explicit parent-child card relations, clarifying the sequence of drug development phases and ensuring regulatory steps are not missed.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Real-time dependency visualization halts redundant work, accelerating the innovation process.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Timely Notifications:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Notifications alert teams to changes in task status or new blocker issues. This maintains a proactive approach, allowing team members to adjust their focus and resources as priorities shift in the fast-paced pharmaceutical landscape.<\/p><p class=\"tekst-para wp-block-paragraph\">   - As a result, compliance risks decrease, and decision-making improves significantly.<\/p><p class=\"tekst-para wp-block-paragraph\">Outcome:<\/p><p class=\"tekst-para wp-block-paragraph\">Implementing KanBo transforms the data domain management process, offering a structured, efficient approach to managing tasks and risks. When barriers arise, card blockers and notifications ensure timely communication and strategic intervention. By resolving date conflicts and mapping task dependencies clearly, the manager secures a robust sequence of operations vital for compliance, reducing financial liabilities by averting delays or failures. This seamless integration of risk visibility mechanisms fosters innovation and enhances the company's reputation, ensuring ongoing success in pharmaceuticals.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section4\">What will change?<\/h3><p class=\"tekst-para wp-block-paragraph\">In the context of a CHC Data Domain Manager in the pharmaceutical industry, transitioning from outdated tools and methods to a modern work management platform like KanBo significantly enhances risk visibility and management. Here's how KanBo replaces old-school approaches:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Manual Task Tracking to Automated Card Management:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Change: Moving from spreadsheets or paper-based tracking to KanBo's card system.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Benefit: Cards represent individual tasks with real-time status updates, eliminating manual errors and providing clear, instant visibility into task progression and blockers.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Lack of Task Dependency Tracking to Card Relations:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Change: Moving from unlinked tasks to KanBo's card relations.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Benefit: Establishing dependencies allows for visual mapping of task orders. This helps in identifying potential bottlenecks early, crucial for complex pharmaceutical projects.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Siloed Communication to Integrated Notifications:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Change: Replacing fragmented email chains with KanBo notifications.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Benefit: Real-time alerts about blockers, date conflicts, and task updates ensure all team members are informed promptly, facilitating better decision-making and risk management.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Ad Hoc Risk Identification to Structured Risk Visibility:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Change: Transitioning from occasional risk reviews to structured use of card blockers (local, global, on-demand).<\/p><p class=\"tekst-para wp-block-paragraph\">   - Benefit: This systematic approach to identifying and categorizing blockers enhances the ability to prioritize and resolve issues quickly, reducing project delays.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Unorganized Information Storage to Centralized Document Management:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Change: From disparate file storage solutions to KanBo's centralized document management.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Benefit: Efficient linking and management of documents across cards and spaces streamline access, thus minimizing the risk of omissions or outdated information impacting the project.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Static Reporting to Dynamic Visualization Tools:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Change: Moving from infrequent reports to KanBo's dynamic visualization tools like Gantt Charts and Time Charts.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Benefit: Real-time visual representations of task timelines and progress help in proactively managing project paths and mitigating risks in pharmaceutical environments where timing is critical.<\/p><p class=\"tekst-para wp-block-paragraph\">7. Limited User Collaboration to Enhanced User Management:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Change: Shifting from limited user roles to KanBo's diverse user management system.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Benefit: Defined roles and access levels enhance collaboration, ensuring that team members work within their competencies, thus reducing the risk of errors due to unauthorized access.<\/p><p class=\"tekst-para wp-block-paragraph\">By adopting KanBo, CHC Data Domain Managers in pharmaceuticals can improve risk visibility, streamline workflows, and enhance compliance and quality control, replacing outdated methods with a comprehensive, modern solution.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section5\">What will not change?<\/h3><p class=\"tekst-para wp-block-paragraph\">In the context of Risk Visibility for CHC Data Domain Manager - Customer in Pharmaceutical, several constants remain unchanged despite technological advancements. Leadership judgment, strategy ownership, and accountability continue to be human responsibilities, where technology serves to amplify these roles rather than replace them. These elements underscore a human-first approach, emphasizing the irreplaceable need for human insight and governance in critical decision-making processes.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section6\">Key management questions (Q\/A)<\/h3><p class=\"tekst-para wp-block-paragraph\">Who did what and when?  <\/p><p class=\"tekst-para wp-block-paragraph\">KanBo's task tracking system records who completed which tasks and their completion times, ensuring accountability and transparency in project progression.<\/p><p class=\"tekst-para wp-block-paragraph\">What threatens the critical path?  <\/p><p class=\"tekst-para wp-block-paragraph\">Potential threats include unresolved global blockers, date conflicts, and unaddressed interdependencies between tasks that could delay critical phases.<\/p><p class=\"tekst-para wp-block-paragraph\">Where are bottlenecks?  <\/p><p class=\"tekst-para wp-block-paragraph\">Bottlenecks are likely found where there are unresolved local blockers or where tasks have high dependencies with delayed predecessors.<\/p><p class=\"tekst-para wp-block-paragraph\">Which tasks are overdue and why?  <\/p><p class=\"tekst-para wp-block-paragraph\">Overdue tasks often arise from mismanaged date conflicts, unresolved blocker issues, or a lack of timely notifications preventing prompt action.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section7\">Atomic Facts<\/h3><p class=\"tekst-para wp-block-paragraph\">- Regulatory Compliance Impact: Non-compliance with agencies like the FDA can result in fines that can exceed millions, facility shutdowns, and significant disruptions in operations.<\/p><p class=\"tekst-para wp-block-paragraph\">- Financial Losses Due to Delays: Unexpected issues extending time to market by 6-12 months can lead to revenue losses from millions to billions, particularly for high-demand pharmaceutical products.<\/p><p class=\"tekst-para wp-block-paragraph\">- Cost of Drug Recalls: Direct costs for drug recalls can average $8 million, excluding the persistent long-term impact on a company's sales and brand reputation.<\/p><p class=\"tekst-para wp-block-paragraph\">- Increased Project Costs: Poor risk visibility can inflate pharmaceutical project expenses by 20-50%, driven by unexpected issues, delays, and the need for process rework.<\/p><p class=\"tekst-para wp-block-paragraph\">- Litigation Risks: Pharmaceutical companies may face legal liabilities ranging from millions to billions in settlements, emphasizing the cost of inadequate risk management and visibility.<\/p><p class=\"tekst-para wp-block-paragraph\">- Impact on Reputation: A single oversight resulting in publicized risk incidents can severely damage a pharmaceutical company's trust and credibility, essential in an industry dependent on perceived safety and efficacy.<\/p><p class=\"tekst-para wp-block-paragraph\">- Risk Management with KanBo: Tools like KanBo enhance risk visibility through visual blockers and notifications, aiding in timely issue resolution, especially critical in pharmaceutical data management.<\/p><p class=\"tekst-para wp-block-paragraph\">- Efficiency Through Mapped Dependencies: KanBo\u2019s card relation feature visualizes task dependencies, helping manage complex pharmaceutical projects, minimizing task overlap risks, and ensuring efficient resource allocation.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section8\">Mini-FAQ<\/h3><p class=\"tekst-para wp-block-paragraph\">1. What is risk visibility in the context of pharmaceutical data management?<\/p><p class=\"tekst-para wp-block-paragraph\">   Risk visibility refers to the ability to recognize, assess, and manage risks that could affect data projects, quality control, and regulatory compliance within the pharmaceutical industry. It involves the use of tools and frameworks to identify potential issues early and take action to mitigate them.<\/p><p class=\"tekst-para wp-block-paragraph\">2. How does KanBo improve risk visibility for CHC Data Domain Managers in the pharmaceutical industry?<\/p><p class=\"tekst-para wp-block-paragraph\">   KanBo enhances risk visibility by providing tools such as visible blockers, mapped dependencies, and real-time notifications. These features help managers identify and resolve impediments, understand task dependencies, and stay updated on critical developments to maintain project momentum and compliance.<\/p><p class=\"tekst-para wp-block-paragraph\">3. What are card blockers and how do they affect risk visibility?<\/p><p class=\"tekst-para wp-block-paragraph\">   Card blockers in KanBo are issues that halt task progression. They are categorized as local, global, or on-demand blockers. By making these blockers visible, managers can prioritize and resolve them effectively, ensuring that risks are addressed promptly to avoid project delays.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Why are mapped dependencies important in managing pharmaceutical projects?<\/p><p class=\"tekst-para wp-block-paragraph\">   Mapped dependencies help visualize the sequence and interrelation of tasks in a project. In pharmaceuticals, where projects often involve complex, interrelated tasks, understanding these dependencies is crucial to identifying potential risks, avoiding bottlenecks, and ensuring efficient workflow.<\/p><p class=\"tekst-para wp-block-paragraph\">5. How do notifications aid in risk management for pharmaceutical data projects?<\/p><p class=\"tekst-para wp-block-paragraph\">   Notifications in KanBo provide real-time updates about critical changes, blockers, and date conflicts. This ensures that team members are informed and can make timely decisions to address issues, maintaining compliance and project momentum.<\/p><p class=\"tekst-para wp-block-paragraph\">6. What are the consequences of inadequate risk visibility in pharmaceutical data management?<\/p><p class=\"tekst-para wp-block-paragraph\">   Inadequate risk visibility can lead to regulatory non-compliance, public health issues, financial losses, and damaged reputation. It can also result in increased project costs, extended time to market, and quality issues such as drug recalls.<\/p><p class=\"tekst-para wp-block-paragraph\">7. How does KanBo facilitate proactive risk management in pharmaceuticals?<\/p><p class=\"tekst-para wp-block-paragraph\">   KanBo\u2019s features such as visible blockers, mapped dependencies, and notifications facilitate proactive risk management by ensuring transparency and enabling quick actions to resolve issues. This helps maintain project quality and compliance, crucial in the pharmaceutical industry.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section9\">Data Table<\/h3><p class=\"tekst-para wp-block-paragraph\">CHC Data Domain Manager - Customer in Pharmaceutical: Risk Visibility Table<\/p><p class=\"tekst-para wp-block-paragraph\">Below is a tabular representation of key data points for a CHC Data Domain Manager focusing on risk visibility within the pharmaceutical industry context:<\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">| Key Aspect                       | Description                                                                                          | Impact                                                                  | Solutions                                                                                   |<\/p><p class=\"tekst-para wp-block-paragraph\">|----------------------------------|------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Regulatory Compliance            | Needs stringent adherence to regulations (FDA, EMA).                                                 | Non-compliance can lead to fines, recalls, or facility closures.       | Implement comprehensive risk management frameworks and technologies like KanBo.            |<\/p><p class=\"tekst-para wp-block-paragraph\">| Public Health                    | Pharmaceuticals impact patient health; undetected risks can lead to adverse reactions.               | Potential harm to patients; legal liabilities.                         | Continuous risk assessment and proactive management.                                       |<\/p><p class=\"tekst-para wp-block-paragraph\">| Financial Performance            | Visibility issues can lead to failed projects, delays, and operational cost increases.               | Project costs up by 20-50%, delayed market entry affects revenue.      | Enhance risk visibility with flexible, adaptable tools and processes.                      |<\/p><p class=\"tekst-para wp-block-paragraph\">| Reputation Management            | Incidents of oversight can damage reputation in a trust-based industry.                             | Long-term negative impact on brand perception.                         | Establish a culture of continuous risk awareness and proactive risk management.             |<\/p><p class=\"tekst-para wp-block-paragraph\">| Innovation and Development Pressures | Balancing speed to market with risk assessment amid rapid innovation.                               | Delays of 6-12 months, resulting in lost revenues.                     | Use tools like KanBo for transparent planning, tracking, and managing risks.               |<\/p><p class=\"tekst-para wp-block-paragraph\">| Card Blocker                     | Impediments in task progression categorized as local, global, on-demand in KanBo.                    | Task delays and workflow disruptions.                                  | Categorize and prioritize blockers for resolution.                                         |<\/p><p class=\"tekst-para wp-block-paragraph\">| Date Conflict                    | Overlap or inconsistency in task scheduling.                                                         | Schedule disruptions in production and research phases.                | Use scheduling tools to anticipate and resolve conflicts.                                  |<\/p><p class=\"tekst-para wp-block-paragraph\">| Card Relation                    | Dependencies between tasks, illustrating task orders and dependencies.                               | Potential bottlenecks in task overlap or dependency mismanagement.      | Visualize dependencies to preempt and address risks.                                       |<\/p><p class=\"tekst-para wp-block-paragraph\">| Notification                     | Real-time alerts on task\/project changes in KanBo.                                                   | Keeps team informed and responsive; maintains project momentum.        | Implement robust notification systems for immediate update dissemination.                  |<\/p><p class=\"tekst-para wp-block-paragraph\">| Risk Impact Quantification       | Description                                                                                          |<\/p><p class=\"tekst-para wp-block-paragraph\">|----------------------------------|------------------------------------------------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Project Costs                    | Increase of 20-50% due to unexpected issues and rework.                                             |<\/p><p class=\"tekst-para wp-block-paragraph\">| Time to Market                   | Delays extend market entry by 6-12 months, impacting revenue significantly.                          |<\/p><p class=\"tekst-para wp-block-paragraph\">| Quality and Recall Costs         | Average cost of $8 million per recall, excluding sales\/reputation impacts.                           |<\/p><p class=\"tekst-para wp-block-paragraph\">| Legal and Fines                  | Settlement fines and lawsuits ranging from millions to billions.                                    |<\/p><p class=\"tekst-para wp-block-paragraph\">| Technologies\/Tools (e.g., KanBo) | Benefits                                                                                             |<\/p><p class=\"tekst-para wp-block-paragraph\">|----------------------------------|------------------------------------------------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Visible Blockers                 | Transparency in issues, aids prioritization and resolution.                                           |<\/p><p class=\"tekst-para wp-block-paragraph\">| Mapped Dependencies              | Visual task dependencies help preemptively identify risks, maintain efficient workflows.             |<\/p><p class=\"tekst-para wp-block-paragraph\">| Notifications                    | Real-time updates keep teams informed, enabling proactive decisions.                                 |<\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">This table provides a concise overview of how risk visibility affects various aspects of pharmaceutical operations and outlines potential solutions and technologies to effectively manage these risks.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section10\">Answer Capsule<\/h3><p class=\"tekst-para wp-block-paragraph\">To address risk visibility for a CHC Data Domain Manager - Customer in the pharmaceutical field, three strategic steps should be implemented:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Implement Advanced Risk Management Tools: Leverage specialized software like KanBo, which caters to the pharmaceutical environment by providing visual management features. These tools allow for the identification and categorization of risks through card blockers, which can be local, global, or on-demand. Utilize these features to identify critical impediments promptly and systematically address them based on priority and potential impact.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Map Dependencies and Conflicts: Use features like card relations to map out task dependencies and identify potential date conflicts early in the project lifecycle. This mapping aids in the timely recognition of bottlenecks and dependencies that might affect the project timeline and helps maintain the integrity of the production and clinical research phases, which are sensitive to timing and coordination.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Enhance Real-time Communication and Alerts: Foster an environment of proactive communication with the help of an efficient notification system. This ensures all stakeholders are alerted to immediate changes, updates, or potential risks as they arise. Real-time notifications help keep everyone aligned on project objectives and empower quick, informed decision-making processes to mitigate risk efficiently.<\/p><p class=\"tekst-para wp-block-paragraph\">By utilizing these methods, risk visibility is enhanced through continuous communication and proactive management, ensuring timely adherence to regulatory standards and safeguarding against financial and reputational losses.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section11\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/h3><p class=\"tekst-para-maly wp-block-paragraph\">```json<\/p><p class=\"tekst-para-maly wp-block-paragraph\">(<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"Article\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Overview\": \"Explores the importance of identifying and managing risks in drug development, manufacturing, and distribution.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Pressure Reasons\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Regulatory Compliance\": \"Avoid fines, recalls, and facility shutdowns due to non-compliance with agencies like FDA and EMA.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Public Health\": \"Prevent adverse drug reactions, protecting patient health and reducing legal liabilities.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Financial Performance\": \"Minimize financial losses from failed projects or operational delays.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Reputation Management\": \"Maintain trust and brand perception by preventing oversight incidents.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Innovation and Development Pressure\": \"Balance the need for swift innovation with thorough risk assessment.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Quantifying Risk of Inaction\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Project Costs\": \"20-50% cost increase due to unexpected issues and rework.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Time to Market\": \"Delays can add 6-12 months, resulting in lost revenues.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Quality and Recall Costs\": \"$8 million per recall in direct costs, plus long-term sales impact.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Legal and Fines\": \"Potential liabilities range from millions to billions.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Mitigation Strategies\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Risk Management Framework\": \"Use comprehensive frameworks that adapt to various tools.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Technology Example\": \"KanBo aids in transparency and collaboration via visual boards and proactive risk awareness.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"KanBo Features for Risk Visibility\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Visible Blockers\": \"Categorized into local, global, and on-demand to prioritize resolution.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Mapped Dependencies\": \"Visualize task dependencies to prevent bottlenecks.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Notifications\": \"Real-time updates about blockers and changes for timely decision-making.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Application\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"CHC Data Domain Manager Use\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Importance\": \"Enhanced risk visibility is crucial for data project management, quality control, and regulatory compliance.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Key Terms\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">          \"Card Blocker\": \"Impediments halting tasks, categorized for prioritization.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">          \"Date Conflict\": \"Timing overlap affecting task schedules.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">          \"Card Relation\": \"Task dependency delineation for project phases.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">          \"Notification\": \"Critical updates for timely reactions.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">)<\/p><p class=\"tekst-para-maly wp-block-paragraph\">```<\/p><h3 class=\"wp-block-heading naglowek-start compact-nag\">Additional Resources<\/h3><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-f81cac751942179cffc5595ea3093d69 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-80007a93c5109043d5274205e4d68368 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-23fbce8bb46a861d3991ae1a29f1d971 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:0px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"wp-block-column pasek-prawy spis2 jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-right:16px;padding-left:16px\"><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-40115c86dc2fe150fd9b1ed5dc10196e wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-02abac7c05b8b530fd3b1b7827aca587 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-09306734556c91c46ae8064a30b664b3 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3013,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-71454","page","type-page","status-publish","hentry"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>Navigating the Critical Challenges and Emerging Opportunities in Risk Visibility for Pharmaceutical CHC Data Domain Managers - KanBo<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Navigating the Critical Challenges and Emerging Opportunities in Risk Visibility for Pharmaceutical CHC Data Domain Managers - KanBo\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/\" \/>\r\n<meta property=\"og:site_name\" content=\"KanBo\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"17 minutes\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\\\/\",\"name\":\"Navigating the Critical Challenges and Emerging Opportunities in Risk Visibility for Pharmaceutical CHC Data Domain Managers - KanBo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\"},\"datePublished\":\"2025-09-18T10:24:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industries\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"KanBo for Pharmaceutical\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Navigating the Critical Challenges and Emerging Opportunities in Risk Visibility for Pharmaceutical CHC Data Domain Managers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"name\":\"KanBo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\",\"name\":\"KanBo\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"contentUrl\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"width\":196,\"height\":52,\"caption\":\"KanBo\"},\"image\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Navigating the Critical Challenges and Emerging Opportunities in Risk Visibility for Pharmaceutical CHC Data Domain Managers - KanBo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/","og_locale":"en_US","og_type":"article","og_title":"Navigating the Critical Challenges and Emerging Opportunities in Risk Visibility for Pharmaceutical CHC Data Domain Managers - KanBo","og_url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/","og_site_name":"KanBo","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"17 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/","url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/","name":"Navigating the Critical Challenges and Emerging Opportunities in Risk Visibility for Pharmaceutical CHC Data Domain Managers - KanBo","isPartOf":{"@id":"https:\/\/kanboapp.com\/en\/#website"},"datePublished":"2025-09-18T10:24:14+00:00","breadcrumb":{"@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-the-critical-challenges-and-emerging-opportunities-in-risk-visibility-for-pharmaceutical-chc-data-domain-managers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kanboapp.com\/en\/"},{"@type":"ListItem","position":2,"name":"Industries","item":"https:\/\/kanboapp.com\/en\/industries\/"},{"@type":"ListItem","position":3,"name":"KanBo for Pharmaceutical","item":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/"},{"@type":"ListItem","position":4,"name":"Navigating the Critical Challenges and Emerging Opportunities in Risk Visibility for Pharmaceutical CHC Data Domain Managers"}]},{"@type":"WebSite","@id":"https:\/\/kanboapp.com\/en\/#website","url":"https:\/\/kanboapp.com\/en\/","name":"KanBo","description":"","publisher":{"@id":"https:\/\/kanboapp.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kanboapp.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kanboapp.com\/en\/#organization","name":"KanBo","url":"https:\/\/kanboapp.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","contentUrl":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","width":196,"height":52,"caption":"KanBo"},"image":{"@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/comments?post=71454"}],"version-history":[{"count":0,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71454\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/3013"}],"wp:attachment":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/media?parent=71454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}